2.0
12 Jul 2025
Anonymous employee
Former employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
Decent pipeline. Management especially in tech ops and clin are seasoned drug development leaders
Cons
lack of transparency on specific vision, Competition in the field is heating up. Science runs as operation only.